Table 1 Demographics of the participants and baseline characteristics of CMVR in this study

Age (years), mean ± SD (range)

43.4 ± 16.8 (20 ~ 67)

42.8 ± 17.3 (23 ~ 68)

Sex (male/female)

22/3

19/6

Eyes (bilateral/unilateral)

11/14

6/19

Duration of HIV, years

Median ± IQR (range)

3.0 ± 2.5 (0.4 ~ 7)

3.0 ± 5.0 (0.2 ~ 9)

HIV suppression rate

61%

69%

Duration of eye symptoms, days,

median ± IQR (range)

32.0 ± 46.5 (3 ~ 180)

30.0 ± 35.5 (5 ~ 180)

Intraocular pressure (mmHg),

median ± IQR (range)

13.2 ± 4.5 (9.0 ~ 19.8)

14.1 ± 5.2 (8.5 ~ 20.0)

BCVA (logMAR),

median ± IQR (range)

1.2 ± 1.4 (0.2 ~ 2.7)

0.9 ± 1.8 (0.1 ~ 2.7)

Lesion location (Zone I/Zone II)

25/11

17/14

CD4⁺ T-cell count (cells/mm³)

median ± IQR (range)

22.5 ± 28.5 (1–177)

27.8 ± 22.1 (3–278)

HIV virus load (copies·mL^− 1) Median ± IQR (range)

118 ± 2318.5(22–6793)

159 ± 1979.7 (25–8521)

Intraocular CMV DNA load (copies/mL) median ± IQR

(3.5 ± 2.0) ×10⁴

(4.3 ± 6.3) ×10⁴